Clinical Trial Update: Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection [Phase 3]

View source ↗

Summary

Phase 3 trial comparing TAK-438 (Vonoprazan) to Lansoprazole in duodenal ulcer treatment, with or without Helicobacter pylori infection; study completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer

Drugs mentioned

• Lansoprazole (Lansoprazole)
• TAK-438 (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Duodenal Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2020-06-12